YaoshiBang Unveils 'Pharmaceutical Broad Market User Data Report' at 2021 Xipu Conference, Highlighting Online Behavioral Trends of Retail Pharmacies and Third-Tier Terminals

The 2021 West China Pharmaceutical Conference (Xipu Hui) featured a special session hosted by YSB Inc., titled “Industrial Internet: Redefining Efficiency,” held on the evening of September 24. The event was attended by more than 200 renowned domestic and international pharmaceutical companies. At the conference, YSB Inc. premiered its “Report on User Data in the Broad Pharmaceutical Market,” providing an in-depth analysis of the online behavioral characteristics of retail pharmacies and the third-tier terminal market. The strategic cooperation ceremony between YSB Inc. and the 2021 West China Pharmaceutical Conference was also officially launched at the event.

Special guests Xu Keyi, Deputy Director of GPC’s Da Nan Yao division and General Manager of Baiyunshan Hehuang Chinese Medicine, and renowned media personality Qin Shuo, delivered insightful speeches at the conference.

The theme of this year's Xipu Conference is "Efficiency Revolution." At a time when the industry is undergoing dramatic changes, maximizing production efficiency, marketing and promotion efficiency, and distribution efficiency in the pharmaceutical sector represents the arena where the industry must redefine efficiency.The industrial internet will create the greatest value in enhancing efficiency.

“The implementation path of the industrial internet must feature four ‘modernizations,’"Software-based implementation achieves overall collaboration, online-based implementation enables second-level perception and feedback, digital-based implementation ensures precise measurement and iteration, and intelligence-based implementation realizes automated processes and intelligent decision-making." In the industrial internet,The entire industrial system functions like a human body; only by possessing “modern” characteristics can issues in any area be rapidly transmitted to the “brain,” enabling interconnectivity, precise measurement, and iterative improvement, ultimately helping enterprises achieve intelligent decision-making.

Over the past five years, through continuous investment in online platforms, software solutions, and digitalization, YSB Inc. has continuously integrated various nodes of the industry chain, achieving connectivity and business synergy across all segments of the pharmaceutical supply chain. By establishing this foundation for modernization,YSB Inc. has gradually developed intelligent capabilities, such as maintaining an inventory turnover period of under 20 days and providing second-level financial credit approval.Only with the enhancement of these capabilities can stakeholders across the industry achieve real-time interactive collaboration, making every segment of the industrial chain more efficient, streamlined, and mutually beneficial, ultimately leading to a significant boost in overall industrial efficiency.

Renowned media personality Qin Shuo also mentioned in his subsequent sharing, “China is home to hundreds of thousands of independent retail pharmacies, many of which have limited capabilities. YSB Inc. is helping them undergo digital transformation.“Clearly provide users with professional advice; it is absolutely indispensable.”

Leveraging the vast amount of structured big data on its platform, YSB Inc. released the “Report on User Data in the Broad Pharmaceutical Market” for the first time at the conference, presenting an authentic profile of users in this extensive market.

In recent years, driven by relevant policies, the spillover of pharmaceutical distribution outside hospitals has begun to emerge. Correspondingly, the number of retail terminals in the out-of-hospital market continues to increase. The user base, characterized by its large volume and broad reach, will persist for an extended period, while the digitalization of retail terminal operations is accelerating.Taking YSB Inc. as an example, the platform currently serves over 400,000 users, with significant increases observed in user base size, transaction volume, and transaction frequency.

YSB Inc. Big Data Shows Continuous Rapid Growth in Online Transaction Coverage (Number of Users) and Transaction Penetration Rate (Procurement Amount) for Pharmacies and Third-Terminal Clients on the Platform, and given the large user base, it will continue to experience rapid growth in the future. Starting in 2020, chain headquarters have widely adopted online procurement, with digitalization evolving from a supplementary role to a more critical one.

In terms of user behavior characteristics, data shows that online users exhibit "high-frequency" traits. Retail pharmacies place an average of over 30 orders per month, equivalent to one order per day, while chain headquarters reach a frequency of 2–3 orders per day. Furthermore, the number of product varieties purchased by online users has shown significant growth, driven by YSB Inc.’s extensive catalog of over 3 million SKUs and its continuously upgraded and iterated fulfillment capabilities. In terms of marketing formats, C-end models such as "live streaming" and "group buying" have been widely accepted by the online procurement user demographic, primarily aged 30–45, resulting in shorter user decision-making pathways.

Notably, the strategic cooperation ceremony between YSB Inc. and the 2021 West China Pharmaceutical Conference (Xipu Hui) was officially launched at the event. More than ten renowned pharmaceutical manufacturers, including Baiyunshan, Biostime, China Resources Sanjiu, and Shanghai Pharmaceuticals, took the stage to participate in the ceremony. By partnering with YSB Inc., these companies aim to deepen their online presence and jointly explore new avenues for enhancing industry efficiency.

(Launch Ceremony Site)

“3 Million in Sales Within 5 Minutes”: The Case of Baiyunshan Compound Banlangen, a Hit Product Co-created by the Pharmaceutical Company and YSB Inc., Drew Significant Attention at the Event. Xu Keyi, Deputy Director of Guangzhou Pharmaceutical Holdings’ Da Nan Yao Division and General Manager of Baiyunshan Hehuang Chinese Medicine, shared his insights, stating, “Our collaboration with YSB Inc. enables quality medicines to reach end-users directly, significantly enhancing corporate efficiency, leveraging the value of digitalization, and ultimately better serving patients.”

Since 2020, branded pharmaceutical companies including Bayer, Chia Tai Tianqing, Hengrui, AstraZeneca, Xian Janssen, Biostime, Sanjiu, Harbin Pharmaceutical, and Jichuan have all established in-depth collaborations with YSB Inc.